diethylnitrosamine has been researched along with menaquinone 6 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akahane, T; Asada, K; Fukui, H; Ikenaka, Y; Kitade, M; Kuriyama, S; Namisaki, T; Noguchi, R; Tsujimoto, T; Uemura, M; Yamazaki, M; Yanase, K; Yoshii, J; Yoshiji, H | 1 |
| Hayakawa, A; Nagasaka, T; Nakao, A; Sakakima, Y | 1 |
2 other study(ies) available for diethylnitrosamine and menaquinone 6
| Article | Year |
|---|---|
Amelioration of carcinogenesis and tumor growth in the rat liver by combination of vitamin K2 and angiotensin-converting enzyme inhibitor via anti-angiogenic activities.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Transformation, Neoplastic; Diethylnitrosamine; Immunohistochemistry; In Situ Nick-End Labeling; Liver; Liver Neoplasms, Experimental; Mice; Neoplasm Transplantation; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Proliferating Cell Nuclear Antigen; Rats; RNA, Messenger; Vitamin K 2 | 2006 |
Prevention of hepatocarcinogenesis with phosphatidylcholine and menaquinone-4: in vitro and in vivo experiments.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Diet; Diethylnitrosamine; Drug Synergism; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Phenobarbital; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Vitamin K 2 | 2007 |